Strategic Clarity. Global Insight. Real-world Impact
Brena Global: where leaders come for decisive insight.
Marketing Intelligence & Strategy
Deep analysis of HealthTech trends, competitive landscapes, and innovation opportunities across U.S. and EU markets.
Strategic Delivery
Product & Commercialization Strategy
Guidance from concept through regulatory readiness and launch balancing speed, compliance, and market fit.
As an advisor who could synthesize 20 years of domain expertise into a single, high-impact consultation, I equipped the client with:
A clear diagnostic of which U.S. MedTech verticals are experiencing investment acceleration vs saturation
Early indicators that distinguish fundable startups from high-risk ones
A roadmap for how CDMOs shape speed, cost, and technical success
Regulatory and commercial inflection points across the five device categories
Funding landscape patterns influencing Series A–C outcomes
Featured Case Study
-
The consultation enabled the client to:
Position their investment thesis with greater accuracy and confidence
Identify high-potential U.S. technologies aligned with their growth strategy
Avoid costly engagement with startups lacking regulatory or technical viability
-
The client received a framework providing potential to:
Understand CDMO leverage points that reduce time-to-market by 12–18 months
Recognize which emerging technologies will reshape cardiovascular and neuro-based interventions in the next 3–5 years
-
The client was provided clear, actionable, evidence-backed framework for evaluating U.S. MedTech startups and CDMOs enhancing internal analysis and accelerating their decision cycles.
Leadership & Ecosystem Development
Global Insight Delivered on Demand: Guiding a Singapore Corporate Innovation Team Through the Complex U.S. MedTech & CDMO Landscape
Advisory for boards, accelerators, and innovation teams on building equitable, high-performing organizations.
Client Need (Problem Statement)
A Singapore-based corporate innovation team needed rapid, expert clarity on the U.S. MedTech startup ecosystem to refine their investment strategy across multiple high-growth device categories. They required:
A panoramic view of the U.S. MedTech market
Understanding of startup quality signals and failure patterns
Insight on CDMO partnerships for early- and mid-stage companies
Strategic differentiation across cardio, structural heart, neuromodulation, EP, and vascular
A framework to evaluate technical readiness, regulatory pathways, and funding momentum
